Britain’s push to reform whistleblower protection risks creating a system that rewards high-value financial cases while leaving NHS and public-sector whistleblowers exposed, according to a new documentary challenging one of the most influential proposals now circulating in Westminster.

Whistleblower INC, a 30-minute film from JAM Motion Pictures, argues that the proposed creation of an independent “Office of the Whistleblower” could reshape whistleblowing around money, litigation and political access rather than public interest. The film warns that a reward-based model, partly inspired by American whistleblower bounty schemes, may draw resources towards banking, fraud and cryptocurrency cases while doing little for workers who raise concerns about patient safety, institutional failure or abuse inside the NHS.

That concern is not abstract. During the making of the film, NHS whistleblowers told producers they had approached WhistleblowersUK, or WBUK, for help but were turned away or left unsupported. Their experiences sit at the centre of the documentary’s warning: that a future system built around financial incentives could amplify already powerful cases while those exposing harm in healthcare remain marginalised.

The film’s central question is blunt: if Britain builds a whistleblower regime that pays out on recoverable fraud, who gets protected — the banker with a case worth millions, or the nurse warning that patients are being put at risk?

The documentary, released online after a premiere at the Frontline Club in London, presents the current legal framework, centred on the Public Interest Disclosure Act, or PIDA, as broken. But it argues that the proposed solution could make a bad system worse by turning whistleblowing into an industry.

At the sharp end of that critique is failed Norwegian businessman and Conservative Party donor, Christen Ager-Hanssen, a WBUK ambassador whose prominence in whistleblowing circles is presented by the film as a warning about the type of figure who can thrive when whistleblowing becomes entangled with money, litigation and political influence.

In April 2024, the Guardian reported that Ager-Hanssen had been invited to a private dinner with then home secretary Suella Braverman after the cryptocurrency and software company he ran, donated £70,000 to the Conservative Party. The report said the invitation came while Ager-Hanssen was presenting himself as a man with access to covert surveillance capabilities and former intelligence officers, and while he was involved in disputes inside the cryptocurrency world.

The Guardian described him as a self-styled “street fighter” with a history of using hidden recording, covert surveillance and sting-style tactics. It reported that he had spoken of assembling teams that included former intelligence officers from the CIA, MI6 and Mossad, and had boasted of using concealed microphones in meetings.

For Whistleblower INC, the relevance of Ager-Hanssen’s story is not simply that it is colourful. It is that it shows how whistleblowing can become attractive to powerful, wealthy and politically connected actors when financial reward and legal leverage are placed at the centre of the system.

The Guardian also reported that, on the same day Ager-Hanssen said he had spoken to then prime minister Rishi Sunak at a Conservative fundraiser, emails showed he proposed a “True Blue” app to Conservative Party officials. The proposed app, according to the report, would have used Conservative Party member data to allow brands to sell directly to party members, potentially generating millions for the party. The project was later abandoned.

The £70,000 donation later became controversial. According to the Guardian, the company said it had only learned of the donation after Ager-Hanssen had been dismissed, and that there had been “no board or shareholder approval” for it. The firm said Ager-Hanssen had been fired after conducting himself in what it called a “serious and inappropriate manner”. Ager-Hanssen did not respond to the Guardian’s requests for comment.

The documentary links that controversy to a wider concern about the proposed whistleblower reform model. If a new Office of the Whistleblower is funded by fines and penalties, critics argue, it may be drawn towards cases with the biggest financial return. That means fraud, banking and corporate misconduct could become the most attractive cases, while disclosures about unsafe care, institutional bullying, patient deaths or systemic failures in the NHS may remain neglected because they do not carry the same financial upside.

That is the film’s most politically explosive claim: the UK could end up incentivising whistleblowing for bankers while failing to protect the NHS staff, care workers, teachers and public servants whose disclosures may save lives but not generate large recoveries.

The documentary says Ager-Hanssen continued to be championed by WBUK despite court rulings that, it says, went against the merit of his claims. It cites internal criticism suggesting the appeal of the case lay not only in its visibility but in the prospect of a £250,000 payout. In the film’s framing, that becomes a case study in incentive distortion: once money becomes central, disputed or weak claims can command attention while ordinary whistleblowers are left outside the door.

The film’s critique of WBUK goes beyond one individual. It examines the organisation’s role in backing the proposed Office of the Whistleblower and raises questions about lobbying, parliamentary access and transparency. According to the documentary, WBUK acts as the secretariat for an All-Party Parliamentary Group connected to whistleblowing reform. The film asks how that work is funded and whether there is enough transparency around who is shaping reform.

It also raises concerns about the possible involvement of U.S. law firms with experience in reward-based whistleblower cases. The film does not present those questions as settled findings, but as matters requiring public scrutiny before Britain adopts a new system.

At ground level, the documentary scrutinises the economics of advocacy itself. It says WBUK requires people to pay £10 a month to become associate members and reports that some junior barristers working on cases charge £100 an hour for assistance. Testimony included in the film alleges that people who cannot afford those costs may be overlooked, while higher-profile cases with the potential for larger financial rewards receive more attention.

That allegation is especially serious in the context of NHS whistleblowers who say they have already struggled to find support. Many health-sector whistleblowers do not come forward with evidence of recoverable fraud. They come forward with warnings about patient harm, unsafe staffing, bullying, cover-ups or institutional neglect. Their disclosures may be urgent and life-saving, but they do not fit neatly into a reward-based model built around financial penalties.

Several contributors to the film argue that this is the moral fault line in the reform debate. Whistleblowing, they say, should be treated as an act of public service requiring protection. Instead, they fear it is being recast as a business opportunity.

The proposed Office of the Whistleblower is presented by supporters as a way to give whistleblowers a clearer, stronger route to justice. Whistleblower INC argues that the opposite could happen. According to the film, the office would wield enormous power: deciding who qualifies as a whistleblower, what penalties should be imposed on companies and what level of compensation should be paid.

Critics in the documentary say that would mark a sharp shift away from the current judge-led tribunal process and other oversight mechanisms. Their fear is that a single body could become gatekeeper, investigator, adjudicator and financial beneficiary of the system it controls.

If that body is funded by the fines it imposes, the film argues, the conflict becomes even sharper. A self-funding regulator would have a built-in incentive to pursue the most lucrative cases. In practice, that could mean chasing corporate fraud while leaving lower-value but higher-harm cases — including those from the NHS — without meaningful support.

The documentary does not deny that fraud is a serious national problem. Nor does it argue that financial-sector whistleblowers should be ignored. Its argument is that reform designed around fraud recovery may fail to protect the broader class of whistleblowers who suffer retaliation for speaking out in the public interest.

The film uses the experiences of former whistleblowers Martin Woods and Wendy Addison to show how severe the personal cost of speaking out can be. Their cases are presented as examples of professional blacklisting, financial ruin and long-term isolation. The message is that whistleblowers already pay a heavy price — and that any reform worthy of the name must protect people before they are destroyed, not merely reward a select few after money has been recovered.

That is why the NHS question runs through the film. In healthcare, the cost of silence is not only financial. It can be measured in patient harm, avoidable deaths and institutional failure. Yet those cases may be precisely the ones least likely to benefit from a reward model focused on penalties, recoveries and large financial claims.

The producers say the film was made “in the public interest” and is intended to widen, not shut down, the debate. In a statement released alongside the documentary, they said the project addresses what many in the sector see as the central tension in whistleblowing reform: the prioritisation of “high-profile, financially lucrative cases” over whistleblowers from other sectors, many of whom feel “overlooked and unsupported”.

They also acknowledge that the focus on major financial cases may reflect “political and financial realities”. But, they add, “the conversation must include all sides of the debate. Parliament needs to listen.”

By placing Ager-Hanssen, WBUK, political access and NHS whistleblowers in the same frame, Whistleblower INC asks whether Britain is about to solve the wrong problem. The country already has a weak whistleblower protection system. The danger, the film suggests, is that reform could build a louder, richer and more professionalised market around whistleblowing without protecting those most at risk.

The question is no longer simply whether Britain needs a new whistleblowing law. Almost everyone in the debate accepts that it does. The question is who that law is really for.

If the answer is bankers, fraud lawyers and politically connected claimants, while NHS staff and other public-interest whistleblowers remain unsupported, then the reform may not be reform at all. It may be a new industry — built in the name of whistleblowers, but not for the ones who need it most.